Skip to main content
. 2014 Nov 17;2014(11):CD008726. doi: 10.1002/14651858.CD008726.pub2

Shah 1998.

Methods RCT. Individual women. 4‐arm study.
Participants Inclusion criteria
  • Women undergoing elective CS.

  • N = 147 in the cephalosporin comparisons (198 in total).


Exclusion criteria
  • Women who gave history of hypersensitivity to penicillin or cephalosporin and those having received antibiotic therapy within the last 3 days prior to surgery; women with severe hepato‐renal insufficiency (total bilirubin > 3 mg/100 ml and/or serum creatinine > 2.5 mg/100 ml); women with positive cultures prior to operation; definite clinical or laboratory evidence of infection where sampling for culture was not possible.

Interventions Intervention: cephalosporin (B1) combination.
  • Cephradine + metronidazole.

  • 3 doses of 500 mg cephradine + 500 mg metronidazole; IV.

  • N = 47.


Comparison 1: penicillin (A3).
  • Piperacillin ‐ single dose.

  • 4 g; IV.

  • N = 48.


Comparison 2: penicillin (A3).
  • Piperacillin ‐ multiple doses.

  • 3 doses of 2 g each; IV.

  • N = 52.


Comparison 3: Data not included in this review.
  • No antibiotics.

  • Did not receive any prophylactic antibiotic and served as the control group. No other antibiotic was administered to any of these women during the study period.

  • N = 51.

Outcomes Post‐operative febrile morbidity; metritis with pelvic cellulitis; wound infection.
Notes Dates: January 1995 to mid‐1996.
Setting: Abu‐Dhabi, United Arab Emirates.
Subgroups
  1. Elective CS.

  2. After cord clamping.

  3. IV administration.

  4. Single and multiple doses.

  • Comparisons: 1 (subgroup 3); 2; 3; 4; 5.

  • Single and multiple doses were pooled for the comparison between B1 and A3 (Comparison 5).

  • No information about funding source of study.

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Reports women were randomised and no further details.
Allocation concealment (selection bias) Low risk ‘...consecutively numbered sealed envelopes...'.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk No information provided.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No information provided.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 11 out of 198 women (5.6%) were excluded during the course of the study.
Selective reporting (reporting bias) Unclear risk The study protocol was unavailable.
Other bias Unclear risk No information on the baseline characteristics of women in each group. Also other aspects of possible bias were unclear. No information about funding source of study.